Skip to ContentSkip to Navigation
How to find us prof. dr. K.N. (Klaas Nico) Faber

Publications

Anti-TNF alpha treatment in Crohn's disease: Impact on hepatic steatosis, gut-derived hormones and metabolic status

Biomarkers reflecting extracellular matrix turnover and inflammation can be used to monitor disease activity and treatment response in patients with Crohn's disease undergoing infliximab induction therapy

CLINICALLY APPLICABLE INTRALUMINAL PRESERVATION OF HUMAN SMALL BOWEL DOES NOT REDUCE HISTOLOGICAL DAMAGE COMPARED TO STANDARD VASCULAR FLUSH

Collagen release by human hepatic stellate cells requires vitamin C and is efficiently blocked by hydroxylase inhibition

Gender and gut microbiota composition determine hepatic bile acid, metabolic and inflammatory response to a single fast-food meal in healthy adults

How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?

Impaired Hepatic Vitamin A Metabolism in NAFLD Mice Leading to Vitamin A Accumulation in Hepatocytes

Serological biomarkers of type III and IV collagen remodeling predict and monitor infliximab treatment response in patients with Inflammatory Bowel Disease

The Effect of Phenotype and Genotype on the Plasma Proteome in Patients with Inflammatory Bowel Disease

The effect of phenotype and genotype on the plasma proteome in patients with Inflammatory Bowel Disease

Read more